These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2374924)

  • 1. Taming rogue immune reactions.
    Marx J
    Science; 1990 Jul; 249(4966):246-8. PubMed ID: 2374924
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction to checkpoint inhibitors and cancer immunotherapy.
    Sharpe AH
    Immunol Rev; 2017 Mar; 276(1):5-8. PubMed ID: 28258698
    [No Abstract]   [Full Text] [Related]  

  • 3. Identifying strategies for immune intervention.
    Lanzavecchia A
    Science; 1993 May; 260(5110):937-44. PubMed ID: 8493532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-2/IL-2 receptor system: a target for rational immune intervention.
    Waldmann TA
    Immunol Today; 1993 Jun; 14(6):264-70. PubMed ID: 8397768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunology--risk management in the body].
    Kabelitz D
    Dtsch Med Wochenschr; 2005 Jun; 130(25-26):1563-5. PubMed ID: 15965863
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

  • 7. The virtue of tolerance.
    Check E
    Nature; 2002 Jul; 418(6896):364-6. PubMed ID: 12140530
    [No Abstract]   [Full Text] [Related]  

  • 8. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
    Salomon B
    J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cyclosporin A on the immune system.
    Shevach EM
    Annu Rev Immunol; 1985; 3():397-423. PubMed ID: 3933532
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?
    Dick AD
    Br J Ophthalmol; 1995 Jan; 79(1):81-8. PubMed ID: 7880799
    [No Abstract]   [Full Text] [Related]  

  • 11. Insights into autoimmunity: from classical models to current perspectives.
    Gutierrez-Ramos JC; Andreu JL; Moreno de Alboran I; Rodriguez J; Leonardo E; Kroemer G; Marcos MA; Martinez C
    Immunol Rev; 1990 Dec; 118():73-101. PubMed ID: 2079329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in T-lymphocyte response under the action of transfer factor in vivo].
    Buc M; Siska P; Rovenský J; Pruzinec P; Stefanovic J; Pekárek J; Svejcar J
    Bratisl Lek Listy; 1982 Jul; 78(1):63-73. PubMed ID: 6751474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of autoimmune diseases and graft rejection with anti-CD4 antibodies].
    Emmrich F; Burmester G; Horneff G; Emmrich J; Reinke P; Hiepe F; Kalden J; Schulze-Koops H; Volk HD
    Z Gesamte Inn Med; 1992 Nov; 47(11):500-7. PubMed ID: 1361089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts [clinical reference].
    Waldmann TA
    JAMA; 1990 Jan; 263(2):272-4. PubMed ID: 2294293
    [No Abstract]   [Full Text] [Related]  

  • 15. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte adhesion and cellular immune reactions in chronic rejection and graft arteriosclerosis.
    Hansson GK; Geng YJ; Holm J; Stemme S
    Transplant Proc; 1993 Apr; 25(2):2050-1. PubMed ID: 8470268
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
    Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
    Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD3 antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():175-91. PubMed ID: 8461387
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Immunological tolerance.
    Lancet; 1975 Mar; 1(7906):555-6. PubMed ID: 47021
    [No Abstract]   [Full Text] [Related]  

  • 20. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
    Waldmann TA; Dubois S; Tagaya Y
    Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.